Skip to product information
1 of 1

Mouse Anti-Human CD49a Antibody (S-5297)

Mouse Anti-Human CD49a Antibody (S-5297)

Catalog Number: S0B80730 Application: FCM Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen CD49a
Synonyms Integrin alpha-1; CD49 antigen-like family member A; Laminin and collagen receptor; VLA-1; ITGA1
Location Membrane
Accession P56199
Clone Number S-5297
Antibody Type Mouse mAb
Isotype IgG1,k
Isotype Control S0B0617
Application FCM
Reactivity Hu
Positive Sample HeLa
Purification Protein G
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS pH7.4

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 1:200 Hu

Background

CD49a, also known as integrin α1 subunit or the α chain of VLA-1, is a transmembrane glycoprotein encoded by the ITGA1 gene. It is an important member of the integrin family, forming the α1β1 integrin complex through non-covalent association with the β1 subunit (CD29), serving as a cell surface receptor for collagen and laminin. This protein is expressed on various cell types, including activated T cells, monocytes, smooth muscle cells, and endothelial cells, with its extracellular domain containing a critical I-type domain that mediates cell adhesion to collagen and laminin in the extracellular matrix. Beyond its fundamental adhesive functions, CD49a has recently been established as a key marker for tissue-resident memory T cells (TRM) and type 1 innate lymphoid cells (ILC1), among other tissue-resident immune cell populations. Under inflammatory or infectious conditions, it is induced and upregulated by cytokines such as TGF-β and IL-12, promoting the long-term survival of CD8⁺ TRM cells in peripheral tissues like the skin and maintaining their dendritic morphology to facilitate local immune surveillance, while also participating in regulating the migration and function of uterine natural killer (uNK) cells. Furthermore, aberrant CD49a expression is associated with various pathological conditions, including fibrosis, inflammatory diseases, as well as tumor progression and drug resistance, making it a potential therapeutic intervention target.

Picture

FC

Flow cytometric analysis of Raji (Human Burkitt's lymphoma B lymphocyte, left) / HeLa (Human cervix adenocarcinoma epithelial cell, right) labeled with anti–CD49a antibody at 1/200 dilution (1 μg) / (red) compared with a Mouse IgG1,k (black) Isotype Control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti – Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Negative control: Raji